Treatment of hepatitis B virus infection in patients coinfected with HIV

被引：1

作者：

Benhamou, Y ^{[1
]}

Bonyhay, L ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Serv Hepato Gastroenterol, F-75013 Paris, France

来源：

GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2004年 / 33卷 / 03期

关键词：

D O I：

10.1016/j.gtc.2004.04.010

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

This article highlights research into which treatments may be most effective for people with both hepatitis B virus infection and HIV. Studies from the era before highly active antiretroviral therapy and more recent studies are included.

引用

页码：617 / +

页数：12

共 42 条

[1] Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme [J].

Back, NKT ;

Nijhuis, M ;

Keulen, W ;

Boucher, CAB ;

Essink, BBO ;

vanKuilenburg, ABP ;

vanGennip, AH ;

Berkhout, B .

EMBO JOURNAL, 1996, 15 (15) :4040-4049

[2] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[3]

Benhamou Y, 2002, J HEPATOL, V36, P138

[4] Effects of lamivudine on replication of hepatitis B virus in HIV-infected men [J].

Benhamou, Y ;

Katlama, C ;

Lunel, F ;

Coutellier, A ;

Dohin, E ;

Hamm, N ;

Tubiana, R ;

Herson, S ;

Poynard, T ;

Opolon, P .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (09) :705-+

[5] Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus. [J].

Benhamou, Y ;

Tubiana, R ;

Thibault, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) :177-178

[6] Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Calvez, V ;

Fievet, MH ;

Vig, P ;

Gibbs, CS ;

Brosgart, C ;

Fry, J ;

Namini, H ;

Katiama, C ;

Poynard, T .

LANCET, 2001, 358 (9283) :718-723

[7] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Di Martino, V ;

Caumes, E ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (05) :1302-1306

[8] Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine [J].

Bessesen, M ;

Ives, D ;

Condreay, L ;

Lawrence, S ;

Sherman, KE .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1032-1035

[9] THE INFLUENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE DEVELOPMENT OF THE HEPATITIS-B VIRUS CARRIER STATE [J].

BODSWORTH, NJ ;

COOPER, DA ;

DONOVAN, B .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) :1138-1140

[10] Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV [J].

Bonacini, M ;

Kurz, A ;

Locarnini, S ;

Ayres, A ;

Gibbs, C .

GASTROENTEROLOGY, 2002, 122 (01) :244-245

← 1 2 3 4 5 →